CHAMPIONS ONCOLOGY, INC. Proceeds from Common Stock Issued
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2018-04-30, per its 10-K filed 2018-07-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-07-28
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2018-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2018-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2017-10-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2017-07-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2017 was $4.34M.
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2016 was $0.00.
- CHAMPIONS ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2015 was $0.00.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $0.00 derived: sum of 2 quarters · filed 2018-07-30 | $0.00 derived: sum of 3 quarters · filed 2018-07-30 | $0.00 10-K · filed 2018-07-30 | |||
| 2018-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $0.00 derived: sum of 2 quarters · filed 2018-03-19 | $0.00 10-Q · filed 2018-03-19 | $0.00 derived: sum of 4 quarters · filed 2018-07-30 | |||
| 2017-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $0.00 10-Q · filed 2017-12-15 | $0.00 derived: sum of 3 quarters · filed 2018-07-30 | $0.00 derived: sum of 4 quarters · filed 2018-07-30 | |||
| 2017-07-31 | $0.00 10-Q · filed 2017-09-14 | $0.00 derived: sum of 2 quarters · filed 2018-07-30 | $0.00 derived: sum of 3 quarters · filed 2018-07-30 | $0.00 derived: sum of 4 quarters · filed 2018-07-30 | |||
| 2017-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $0.00 derived: sum of 2 quarters · filed 2018-07-30 | $0.00 derived: sum of 3 quarters · filed 2018-07-30 | $4.34M 10-K · filed 2018-07-30 | |||
| 2017-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $0.00 derived: sum of 2 quarters · filed 2018-03-19 | $4.34M 10-Q · filed 2018-03-19 | $4.34M derived: sum of 4 quarters · filed 2018-03-19 | |||
| 2016-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $4.34M 10-Q · filed 2017-12-15 | $4.34M derived: sum of 3 quarters · filed 2017-12-15 | ||||
| 2016-07-31 | $4.34M 10-Q · filed 2017-09-14 | $4.34M derived: sum of 2 quarters · filed 2017-09-14 | |||||
| 2016-06-15 | $4.30M 10-K · filed 2020-07-28 | ||||||
| 2016-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $0.00 10-K · filed 2017-07-28 | $44.00K 10-K · filed 2016-07-29 | ||||
| 2016-01-31 | $0.00 10-Q · filed 2017-03-17 | ||||||
| 2015-04-30 | $0.00 10-K · filed 2016-07-29 | ||||||
| 2013-01-28 | $9.10M 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |